Decentralized trials

COVID-19 changed the conversation around enrollment and recruitment for clinical trials. Learn how eConsent is helping researchers do more despite restrictions.

Hoboken, New Jersey: December 17, 2020: Castor, a leading provider of clinical trial technology, today announced the launch…

In September 2020, Castor CEO Derk Arts, MD, Ph.D., led a webinar on electronic informed consent (eConsent) challenges…

Industry veterans from leading life sciences companies including Johnson & Johnson, Biogen, and Medtronic, will support the Company’s…

Though technologies that support decentralized clinical trials (DCT) have been readily available for years, meaningful industry adoption has…

The following is an excerpt from our free whitepaper ‘Satisfying PMCF requirements by utilizing IIS data’. Click here…

To support our growing customer base in the APAC region, we established new hosting in Australia. By allowing…

Hoboken, New Jersey: September 2, 2020: Castor, a leading provider of clinical trial technology that automates the research…

With 4,000 live studies and 2M enrolled patients across 90 countries, Castor will use the funding to further…

When the COVID-19 pandemic began, the industry needed to focus immediately on research continuity and determine how to mitigate the impact on clinical trials while protecting participant safety.